THE FRIENDS OF BRISTOL HAEMATOLOGY ANO ONCOLOGY CENTRE
ANNUAL REPORT AND AUDITED FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 21123
Charlty No 264136

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
ANNUAL REPORT AND FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2023
The Tru* was eslablishgd under a tnjsl deed In April 1972 In order to provid8 mli8f to patients at the centre and to support thè work of th
ntre.
The Trust Is a register¢d charty.
Pro$id8nt:
The Lord Ma￿r of 8ri8tol
Offieèrs
Chalr
G•nèral S•Gr•tary
Tm#ur•r
Mrs O Grogono
Mrs E Pfitchard
Mts CM Owen
TTU$tee5
IAr S Blake
Mr8 A Cartton
Mr GJ Clements
Mrs L Oensharn
Mr8 G Creese
Dr G Crichton
Mrs N Day
Mrs O Grogono
Mrs J Lockwood
Mr S Moorlen
Mrs P Murphy
Mrs CM Owen
Mrs S Sims
Mrs A Thomas
Bankèrs
NatSonal Westfflinster Bank plc
Bristol City Offica
Audrto
Elllott Bunker Lirnited
1st Floor 61 P418crae Road
Ham Gr8en
Bristol
BS20 ODD
Stock brtrkers
pha Portfolio Management
1 Tha Square
T￿m￿e Quay
Bristol
Reiistered Offko
Brkstol Haemabl(yay and on￿logY Centre
Horfield Road
Br￿t01
0117 342 3432
Telephone
Pagg 1

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
ANNUAL REPORT AND FINANCIAL STATEMENTS
YEAR ENDED 31 DECEMBER 2023
Tru5te•$' roport
The trust68s wèsent thoir report and Ihe audltod financial statements for th8 year 8ndad 31 Deeèmbar 2023.
The linancEal statements have been prepared in accordance wtth the Statement of Recommended Practice: Accounting and Reportlll9 by
Charities preparty￿ their accounts in accordance wlth the Finanual Reporting Sta￿18[& applicabl8 in the UK and Republic of Irdand
IFRS1021 and thè Financial Reporting Standard 8pplle8ble in the United KFngdom and Republsc of Ire18nd IFRS102} and the Charit￿$ Act
2011 and UK Ganèraly A¢¢epted Practica as it appltes from 1 J8IIU8ry 2015
Constitution and objects
Thg Trust was constitut8d under the mod81 deed for Friends of Hospitals. A revised constitution was adopted in September 2(M)6. The
prinapal obiect of the Trust a$ set out in thp constllutil￿ is to offer relief to paI￿ntS and former patients and lo support thè work of thg
Centre.
During the year, the charitys main objectives continued to be Ihose of fundr8ising and m8nagement of th8 invéslment portfob'o, enafrAiThJ
flnancial supw>rt to be given to the Brfstol Haematdogy and Oneol(w Centre in reSp￿t of speclfic projects.
The trust688 confimi that th8y hav8 referred to the guidance contained in the Charliy Commissloners, general guidance on Publ￿ bertefil
when reviewing Ihe Trust's aims and objecl*ves and in planning lutufe funding of the Cèrbtrè.
struetur• and organlzatlo
Thé Trust is unincorporal8d and is a registered charity. The l¥usiees kn offlce during the year and at th& dotg of thkg rgport are 8S 8el out on
page 1.
A main commTrttee as set out IFF the (x)nstiIul￿￿ manages the Twst. Meetings are held quarterty iand are attended by FepTesenta*'v8s from
thg h05Pital. TFustees are invited to join the committee by existing trustees or by recommendations from hospitsl Staff. In additv)n to the
main committee there is an investment commitle& which has rèsponslbllty for inv8*lng the Trust's r8serve5.
The inv&stment commirte8 is thairad by Mr8 O Grogono. Th& followlng trustees also seNe on eommittÈe: Mr GJ Clements. and Mrs
CM Owen.
Revlèw of activities and future develownents
DuTlng the year th& Trust has ¢orttinued to raise money to benefft the patients of The Bristol Ha8rn8tology 8nd Oncdogy Centre. The
lundrdising is 5argely i%rried out by volunteers and th• trustees are very gr816(ul to thè many volunteers who carried out fund rai8tng
activities on behalf of the Trvsl during the yeat.
The Trust has, and will contlnue to. support the work of the h05pilal by financlng various capital and rgs8arch proj8cts undertaken by the
howtal and Br&8tol University.
Flnaneial activllles and affairs
There have been no eh8nges in thè polKTe8 ofthe Twst during the year.
During the year IncomltvJ resources from fundr8ising, donations and legacies and investment IN(x)me tota118d £221,48712022.' £300,712,
and èxpènditure on spwfic projects amouTrted to £140,278 12022.. £110,939). After ded￿tIng the charivs operating expenses and
allowing for thg reallsed and unrealised Invastmènl rgv8luatiw sur￿u88$ the rgsultiThJ surplus lor the yoar wos £252.175 {2022..defi(xl
£243,559).
At the year end the Tfust's balanc* $hg¥1 SP￿1811 totsl lund8 of £5,356,70212022'. £5,104,527> of whSch £5.309,814 12022.. £5,054,3961
were unrestrfcted funds.
Pagè 2

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
ANNUAL REPORT AND FINANCIAL STATEMENTS
YEAR ENOED 31 DECEMBER 2023
R•8*rves
The unrestFiCted fund represents the 8c(yJmulated surpluses from ptevious years. The ￿1¢Y of tha Trust is to build these res8rves by
jUd￿￿u$ man8gemenl of investment assets to maximise th& in¢orne available for futurè years. The expenditure on charitable objectives
each year depertds on the requests from Ihe hospital man8gement. Wl expenditure is approved by the hospital managernent b￿Ore being
presented to the fNstses al quart8rly meetings. The level of reserves is r8wewed at the meetings and decFsions regarding expenditure is
made by the Trustees h&wng given consideration to available rese￿eS and funds already cornmitted. The TriJst8es keep sufficitnt reserves
to support any long term commitments to the hospital. Surplus Teserves have been Inves￿ to M￿mise inc<Mie and con$equendy
investments are available to be realis&Y 8IK>uld charitable expenditure ?xc£8d availab19 rash in the bank.
The reslricteil funds rsprasont fvnds hdd for specifi¢ puiposes a8 Sèt out in not8 12 to the finandal st8toments
Trust•es' tesponslbllltyfor thè accounts
Law ap￿icable tts d)arities In England and Wales requires tho trustees to prepare fjnaneial statements for each financial year, whKh glve a
twe and lair view of the finani81 advities of thè charity durin9 the year and of its state of 8ff8Srs at the end of the year. In preparing those
financial statements the trustaes are rèquired to:
1. Select $uitable accounting polici8s and apply them consistenyy,
2. Make judgments ar￿ astimales that are reasonable and prud8nt.,
3. Observe the method8 and prindplg$ in th• Charibes SORP
4. State whethw applicatI8 accounting st8ndards and ststements ol recommended practice have been fO￿oWed, subject to any materkgl
departures disdosed and ewèined in the finanoal ststern9nts- and.,
5. Prepare the finan¢Hi statements on the 90ing con￿rn basis u￿88$ It Is inappropriat¢ to presume that th9 Charity VAII tontinue in
operation.
The trvst88s aro responslble lor ke8ping proper aca)unting records. bthich disdosè wtth r￿onable accuracy at any time the financ￿1
posrtion of thè tharity and which enab18 them to ensure that the financ¢al stalemènts CoM￿Y wth sèctth 130 of the Charitles Act 2011 and
ggneral law. They are also résFyJnsible lor safeguarding thè assets of tho chanty and he￿￿ for taking reasonable step5 for the prevention
and datection of fraud and other irregularities.
RiBk managèment
The trustees have assessed Ihe major Tlsks to whtch the Trust Is exwsed, in particular those relatsd to the operdtions and financ8s of the
TTUSt. and are satisfied that syslems afe in place lo mitigate exposure to such risks.
Inve5tm•nt policy
The tnjstees have th8 frt￿er to invest in such as they see f
The investmont cofflfflittee meets at least three times a year lo r&view the investment portfolio and the Cash requtreTnents of thg TrusL For
the last few yoars the Trusvs income has exceeded its requirements and as a r85uIt the inv8Stment strategy is to invest in and m8dium
risk investments to balance capital appreaation with a r&¥sonalJe in¢ome flow to ènable the Iryst to meel 115 objectives.
Approv•d by th• truste•s on I.? and $lgb*d on tholr b•half by.
Mrs Carollng Owèn
TT115tge
P8ue 3

INDEPENDENT AUDrroR'S REPORT TO THE TRUSTEES OF THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY
CENTRE
Oplnlon
We have audited the financi81 statements of The Friends ol Bristd Haematology and Oncology Centfe Ithe"ChariWI for the year ended 31
December 2023 which comprise the Statement ol FinAnaal Activities. Balance Sheet. Statement of Cash Flows and notes to the finandal
ststements. including a sumrnary ofsignificanl 8ccounting polity6s. Th& financial reFK)rtlng framework that has been applied in thelr
preparatlon is appllcable law and United lQngdom Aw)unttng Stand8rds, including Financial RepoFting Standard 102". Th8 Financial
Reporting Standard appliCa￿e in Ihe UK and Republic of Ireland IUnrt8d Kingdom Generally Accepted Accounting PraCt￿e).
In our opinion. th8 financial slatemests-.
' glve a true and fair view of the 5t8tg of th8 Chariil$ aflalrs as at 31 D￿mber 2023 and of its Incomo and expendbturè for the year t
and6d',
. ha￿ been prop8rly pr8pared in 8ccord8nce wrfh United Kingdom G8n6r8lly AetOPted Acwunthng Prathce.
. hav8 beon pr￿ared in arrnrd8nc8 th8 r8quirements of the Charities Act 2011.
Basis fr•r oplnlon
Wo conducted our audit irj attordance vmth Inlem8bon81 Siandards on AudTrting {UKI IISAS IUKII 8nd applicMble18w. Our rèspon3iblilies
undar those standards are further described in the Auditor's responsibilities for Ihe audit of the fin8nci81 ststeriignl$ section of ovr report.
We are IrKlependent of the Charlty In accoidance with the ethical requirements that are r8Jevanl lo our audit of the financial stalements in
thg VK, Induding th8 FRC'S Ethi￿1 Standard, and wa have fulfilled our olh•r ethical reswnslbllttles In accordance with these requlremènts.
We bdieve that the aydf( eviden¢9 wtr ha￿ obtainod 1$ suffi¢lont and ¥pproprlgte to pro￿d8 a basi5 lor our oplnion.
Concluslons rÈlatlng to golng concern
We have nothlng to report In respect of the f￿l￿ng matters tn relatbn to which tt)e ISAS {UKI requke us to report to you where..
. the twstees, use of the going concem basis of accounting in the preparallon of the financlal slaternents is nol appropriate.. or
•the trvslees have nDt disd08ed in th8 finanri$l Statements any identif18d molerial uneertainlies that may ¢a$l $&Jnifieant doubt abtsul Ihe
Charrtls abllilyto continue to adopt the going ￿ncern bas¢3 ol accounting for 8 period of atloast twelve months from the date ¥then the
finanoal statamentg arè authorised for issue.
Othèr Inforni•tlon
Th8 InJslee5 are res￿nsible for the other information. The olher informatK)n comprises th8 infoTmatKM included in the annu81 r8POrt other
than the finaniaal statements and our auditorfs report thereon. Our opinion on the financial statements does not cover the other InfO￿atIOn
and, except to the extent otherwise eXplic￿Y stated in our rewt. wa do not express any fomi of assurance condusion thereon.
In connecllon our audit of the financial staternenls, our responslbnity is to read the other information and. in doing so, consider whether
tho oth8r InI￿rnatIon Is materfally Inconslstent wlth Ihe flnancl81 statèm&ntS Of our kn￿ed9È obt8in611 In the audlt Or ot178tWig6 appears to
be m8teri811y misststed. If we 4dentify suth rn8t8rlÈl inconsist9ncies or app3r8nt rnateri81 rnissla18ments, we 818 r9qUtr8d to dfjtermine
whether there is a material misslalement in the financial statements or a material misstalement of the other inlomalion. If, based on Ihe
we have perfomied, we conclude that there is a material misstatement of this other infomation, we are wuired to rep)rt that fact.
We have nothing lo rety)rt in thls ieg8rd.
Matters on whl¢h wg aro rgqulrgd to r¢port by gxcgpllon
In the light of the kno￿edge and understanding of the Charity and ils environment obtained in the course of the audit. we have not identthed
material misstatements In the TnJsteÈs' Annual Report.
Page 4

We have nolhing to r8port in res￿Cl ol the fdloW￿9 matters in r￿at￿Trn to which tho Charitl&s Act 2011 raquires us to report to you rf, in OUT
opin￿n..
. SUff￿18￿t accounting recorfls have not been kept.
the financsal statern8rnts are not in agreement wilh the acwunung records and returns. or
. ￿ have not oblained all Ihe inlomi8tion explanatson5 necessaryfor the purposes of our audit.
Responslblllttos of the tru5te8s
As 8xp58ined more fvlly in the trustees. responsibd￿eS statement set out on page 3. the trustees are iesponsible fDr the preparation of the
financial statements arKI for being satisfied that they give a true and fair yiew, and for such inlemal contrd as they determine is n8ce&%ary to
en81￿8 th8 preparation of financial statements that are freg from Materi￿ m￿State[lIent. vJh9ther due lo fraud or error.
In preparing the ffinancial st8t&menis, the trusteas are responsible for assessing the Charivs abilty to continue as 8 golng concem.
dlsclosing. as applicable, mattels rèlated to going coN￿M and usirvJ the going concern basis of 8ceountlng unless the IDJStees either int8nd
to Ilquidate ihe Charfty or to C8858 operations, or have no reali*ic altematlve but to do so.
Our resp0nslb151t1￿ for thè audit of the flnaneSal statements
Kèy audlt matters: our assessmont of risks of mat8rlal ml$sfatement
Kéy audit matters are those rnatters that in our profossional judgement were of m05t signfficanco in the audlt ol ihe fin8ndal stslernents and
in¢ludè the most significant assessed rfsks of material misstatement (whèther or not du8 to fraud) identtfied by us, Induding those which
had tho greatest effect on the allocalion of fesources in the audit, and direding the efforts of the engagement tèam. There aro no key area5
identified as the audit IS Very low iisk wth nomal audit procedures adequate in all audit areas.
We agreed to report to ihe board ol trustees any correcled OT unc0￿cted Sdentified misstslements
Identifying and reportlng al rlsks of materfal mlsstat•ment duo to fraud
To ￿len￿ risks of ¥n8tèrial misslatoment due lo fraud we assess8d avents or conditions that could indicate an irsc¥ntN8 or pressur8 to
commit fr8ud or prowde 8n opportunity to commit fraud. Our risk assessment procedur98 inc1￿￿ed.
111 enquirin9 of the truste85 and inspection ol key papers promded to ihose eharged with gov8mance as to high level Oi¢ies and
proceduFes to pravenl and detect frBud.
lill review￿g the minutes of trustses, meetings.
We communicated identthed fraud risks through￿1 tho audit team and femained alert to any indic8tK)ns of Iraud throughoul the audit.
AS wulrad by Auditing Standards, and taking into aceourt OUT overAII knowledge of tha contrd environment, w8 perfomed t￿0￿d￿reS to
assess the risks of management overrfdè of controls. To address the pervaslve risk as it felated to management override of controls. we
revEwed material journ￿ entrfes and agre811 these to supportlng documentath)n where 8PPtopnate.
Identlfylng and r•sponding to rfsk¥ of mat•rlal mlsstat•mont du• to nonwcompllancè wlth laws and r•gulatitsn8
We idèntified areas of laws and re9ulab.ons that could reasonaiAy b8 Èxpected to have a rnaterial effect on the financial statements from our
general commerual and sector experience and through dK%(#Jssion wth the Treasur8r. As the charity Is regulated. our assessrnent of risks
invdved gaining an undetstanding of th8 wntrol environment Induding the entiils procedures for cornpl￿ng wth regulatory requiremenis.
P8ge 5

We communicated identFfied laws and regulatlons throughout our team and r8rnain8d alert lo any indlcatlons of non-compliance IhroUgh￿Jt
the audit.
Auditing star￿ards limit Ihe required audit procedures to identify noTrcompli8nce with these laws and Tegulations tts enquiry of management
arKI trustees 8fKI inspection ol regulatory and legal e￿O$pOndenCe, rf any. Th8r81ore, if any breach of operational regulations is not
disdosed to us or evldent from relevant corresponden¢%. an 8udil will not detect that breach.
Llmltstlon5 to th• ablllty of th• audlt to dètect fraud OT breaches of laws and r•gulatlon
Owing to the Inherent limitation of 8n audit, there is an unaVoida￿e risk that we may not h8V8 d￿t￿ted some material tnisstaternents in the
nancial statement5. even though we have properfy planned Bnd perfomed our audit in accordance wth auditing standards. For eXarn￿e,
the fvrther r8rnoved nOr￿CoMplIance with laws and regulations is from the 8vents and transactions reftected In th8 financial statements, the
less likely the Inher6ndy Ilmtted proceduras roqulred by Audibng Standard5 would hlentify it.
In addibon, as s%ith any8udit. there remained a hpher rlsk of non-detectK)n of Ir8ud, as this may Thivolv8 tolusion, forgery, intenlh)nal
omissK)ns. mlsrepre5entations. ￿ th6 overilde of internal ￿ntrol5. Our audit procedures a￿ desioned to detect material misstataTll8nl, and
therefore we are noi ￿spOr}SIble for prevtrntin9 non-compliance or fraud and canno( be expected to detect non-compliance with 8Jl laws and
regulatiDns.
A further d8scripllon ot our responslbllitias for the audil of the financial statements is knatod on fho Financ¥al RepA)rting CtyJrtil's website al..
ww.frc.ug.ukJaudltoYsrosponslbllitsè5. This descrfpt¢on lom)s part of otsr auditorfs r8P(Wt.
U¥e ol our report
This report is made sdely lo the Charitvs trustees. ?$ a b(Kly. In awjrdance wlth section 144 of the Chaiiugs Acl 2011 and thè regul8tior
made under section 154 01 that Act. Our audit WOFk has been underlaken so that we mtqhl st8te to the Charitys trustees those m8tt8rs we
are required to state to them in an auditorfs r8tK)rt and for no other purpose. To the full85t 8xtent pelmitled by law, we do not a￿8p1 or
assume responsibillty to anyone other than thg Chariiys trustees as a body, for audlt woik. for this report, or for the opinions we have
fomied.
P8uI Cridland
Ell￿tt 8unker Ltd (Chartered AcciMJnt8nts and Stsiulory Auditor)
1 Floor, 61 Ma¢rae Road
Eden Business Park
Ham Green
Bristol BS20 ODO
Date 21
201*
P8w6

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CEKfRE
STATEMENT OF FINANGIALACTMTIES
YEAR ENDED 31 DECEMBER 2023
2023
Unre6trICt￿ R8strlct
fund
fvnds
2022
Restrlet•d
funds
Total
Unr•strl¢ted
fund
Total
Note
Income and endowments
from
Don8tions and leyaeies
Othef trading acti￿lIeS
Investment In￿rne
83,111
2,836
108,537
26,718
109,829
2.836
108.822
136,299
37,066
98,027
29,2S8
165.557
37.066
98,089
285
Total
194,484
27,003
221,487
271,392
29.320
3(X).712
Expenditure on
Raisiry funds
Charitst4e 8¢1ivlbes
2,263
184.070
17,997
90.914
17,997
152.706
86,556
97,514
61.792
Tolal
88,819
97,514
186.333
108.911
61.792
170,703
Net income
105.865
170,5111
35,154
162.481
(32,4721
130,009
Trdnsfers
Gross transfefs between lunds
Net incorne bef￿e other
r8cognised gains and
losses
167,2681
67,268
132.2461
32.246
38.397
13.2431
35,154
130,235
1226)
130.CK19
OTHER RECOGNISED GAINS
ILos88sygains on inv8stments
R6dised 98ins on diswsals
Un￿alls￿d gam1￿{k)Ssesl on
aluations
83,313
83.313
220.678
220,678
133.708
133,708
1594,246)
1594,246)
Net movement In furKI
255.418
13,2431
252.175
243.3331
12261
1243,559)
Total funds brought forward
5.054,396
50.131
5.104.527
5,297.729
50,357
5,348.086
Total funds carri•d forward
5,309,814
46,888
5,356,702
5.05S.396
50,131
5,104,527
All actiwiÉes relate to continuinu operath)ns.
galns and k)sses r8cognk8ed in the year are Indud9d in the Statement of Finonc481 Activities.
Pago 7

THE FIIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CEKfRE
BALANCE SHEET
YEAR ENDED 31 DECEMBER 2023
Notè
2023
2022
FIXED ASSETS
Investments
4.603.040
4,411.702
CURRENT ASS￿3
Debtors
10
1.549
759.$41
761,190
30,0
672.005
702,005
Cash at bank and hand
CREDITORS: amounts falllng due wlthln one
7,528
9,180
Nel ¢urrent assets
753,662
692.825
Totsl a88•ts less current Ilabllltles
5.356.702
5,104,527
Fund$
Unrestr￿ted fund
12
5,309.814
46,888
5,054.3
50.131
Restricted fund
5,356.702
5,104,527
Approved and authoris8d for i5SUg by th8 Trustees on I .1
Is12
and sIg￿￿ on Ihdr behalf by
Mrs O Grogono- Chair
The rK)t6s on pages 10 to 15 fomi an intggral part of thèse acwunts.
Poge 8

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
STATEMENT OF CASH FLOW
YEAR ENDED 31 DECEMBER 2023
Total Funds
2023
Total Funds
2022
Net ¢a5h g•MYated by oporattng a¢tiviilÈs
15
{46,8691
997
Cash from investing aetwities
IntgrgSt and dividends
T￿n$fer from stockbroker
108,822
25,683
98.089
25,728
Cash provbd•d by invÈstin9 activities
134,505
123,817
Change In cash •nd eash equivalent¥ In the yoar
87.636
124,814
Cash and cash oquivalents brought forward
672,005
547,191
C•5h and cash equival•nts caffièd forward
759.641
672,005
P896 9

THE FRIENDS OF BRISTOL HAEMAfoLOGY AND ONCOLOGY CENTrE
NOTES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED
31 DECEMBER 2023
Accountlng poliei•8
Basis of prep8raf¥)n 8nd s￿83Ment of golng coneem
The finan￿al statemenls have begn prepared under th8 historical cost corwenlion. as rTM)dified by the revaluation of certain fixed assets,
and in accordance with the Slalemenl of Recommended Pr8ct%ce 'Accountlllg 8nd Reporting by Ch8rthes prep8r5ng their accounts i
accordance with Financial Reporting Standard applI￿ble in the UK and Republi¢ of Ir91and' IFRS1021, 8ppIiG8ble ac(thnting standards and
the Ch&rities Act 2011.
Thg Ttust COn5titut8s a publlc benefit entity as defined by FRS102.
Ineomlng resoufces
DonatNin8 ar8 accountéd for when r&c6ived by Ihe Trust and lagactos are rerA)gnised when it i8 probable thal they wll be rec£ived. Other
irbcome is accwrted for on an accruals basis 85 far as il is prudent to do so. Incom& includtss incom8 tax recoverable.
Roourc￿ èxp•ndad
Liabilitth are recognise(* as soon as there Is a legal ￿ C4)nstn￿t1ve oNigation commiltln9 the charity to the expenditure. All ewendlture Is
accounl6d lor on an accruals basis and has been Cla￿rIed under headings that aggregat8 all costs related lo the category.
charita￿ expendliure comprisas those costs incunBd by the charity in Ihe dolfvery of its actlvities and 5eNIc65 for Its beneficiaries. It
indud8s both CA)Sts that can b8 dir8Ctty alloc3t8d to Ihe actwity arml indlrect costs required to support the work (rf th8 tharlty.
Glfts In klnd
The Trust r￿s4Ve5 the benefft ol work carried out by vdunte8r3 8rKI is allocated 8 room at the Cgntre frge of clwge. No value 18 p￿¢8￿ on
those Items.
Taxatlon
As a registered ch8rity. the trust is éxèmpt from tax #s IL h8s no laxaL4& 8clivsl￿. Irrècov6rÈbl8 VAT L¥Jrn8 by tha Trust IS Fndud8d In thè
Cost th the item to whith il rel8t¥$.
Investments
Investment ts)come Is taken Into account on the basls of the due dale ol payment. Investsnents are a lorm of basic financlal knslmment and
are initially reciyJnised at their transaclion value and subsequenuy measured at their lair value as at the balance sheet date using the
dosing qlloted market price. All gains and losses, whether realised or unrealised are credited or charged to the Unrestricted Fund.
Fund a¢￿untIng
Unrestricted in¢om& tund$ ar8 9￿Or$I fvnds that are av8il#bJe for use 8t the Tru$t8e$' dIS¢ret￿ in fvrlherance of the objo¢tives of the
charity.
Restricted funds are those donated for use in A p8rtkul8r area ￿f0* a spteffic purposè. tho Uso of which is ￿$trICt&d to that Area.
Det8ils of th8 natur8 and purpos& of each fvnd is set out in nots 12.
G¢)v•maneè ¢osts
())vernance costs include costs of the preparatlon and examlnation of the Report and FIna￿F81 Statement. (osts relattng to Trugtees.
moetings and any18gal costs roFat6ng to gtsv8rnanc8 and conslitutK)nal m8ttars.
2. Tran￿¢tIOnS wlth Tn•Btees and other connected persons
No transactions took place bethen the Trust and the Truslees or any persons connected with them.
Page 10

E FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
TES TO THE FINANCIAL STATEMENTS FOR THE YEAR ENDED
DECEMBER 2023
Fixed •ss•t Inv•stments
2023
2022
Ltsted Inv•sthi•nts at markot
value
Fixgd intefest seCurft￿S
Equfy shwes
Investmerit trusts and unlt trusts
912.983
3,479.626
196.163
4,59LTr.772
12,268
4,603,(140
730,847
3.210,276
269,977
4,211.100
200,602
4,411,702
Cash
Hl#torb¢al eost of Ilst8d Invostmont8
4.334,236
4,088,267
Listed
invèstments
Cash
Total
Mark&t value..
At 31 D8cember 2022
Additions
4,211,100
675,951
I4￿,987)
133,7(18
200,602
513,300
1675.951
4.411,702
1.189.251
11.105,9381
133,708
125,6831
Disposals
Incrèasa in value in year
Transfer to income
125,6831
At 31 December 2023
4,5￿.772
12,268
4.603,040
At 31 Decernber 2023 there ￿r6 holdings with a mart(et value in èxeess of SYD of the totsl valve. A hokling of S&P I shares had a
market value of £430,100 arKI a hokling ol Vanguard FTSE Developed Worfd had a market value of £336,877.
, D•btors
2023
2022
PrepaT(l expen898
LegaC￿S due
1.549
30.000
1.549
30.0(X)
Cr•dltors: amounts falling withln onè ￿ar
2023
2022
A{￿rUed èxpenses
UnpaMI invoices
7.528
9,180
7,528
9,180
Pago13

THE FRIENDS OF BRISTOL HAEMATOLOGY AND ONCOLOGY CENTRE
NOTES TO THE FINANCIAL STATEMENfs FOR THE YEAR ENDED
31 DECEhlBER 20
12. Funds
At31
D袕mb•r
2022
Transfern
between
funds
At31
December
2023
Ineomlng
R￿ourceS
expended
R•$trfctsd Funds
Equipfftent fund- to PUTthase and malnt8ln
medical equipmgnt
Rosearch Fund- to furvj resgarch projects
Marsden bequest- io lund research salaries
E8m)arked fund- grfts fo¥ other purposes
2,687
22,121
1.467
23,856
50,131
21,471
267
91.426
67,268
22,388
1.485
Y3.015
46,888
t8
5,247
27.003
6,088
97.514
67,268
Unr¢strlcted fvnds
Gen8ral fund
5,054.396
5.104,527
411,505
438.508
88,819
186,333
{67,2681
5,309,814
5,356.702
1& Analysls of n•t as8•ts b•lwwn funds
Unrestricied
Funds
Restricled
Funds
Tot81 Funds
2023
Invostrnents
4,603,040
714.302
17,5281
5.309.814
4,603,040
761,190
17,5281
5,356,702
Current assels
46,888
Cr8ditors du& within one ye
46,888
1*L Approved futur• fvndlng
At 31 Decembèr 2023 the lrnst had ont&r8d into Ihe followng funding commitments.
Courses for hospftal staff
Informatlon support research salaries
Chefflotherapy trgalment chairs
R8diotherapy planning trial
F8tigu8 8pp devgloprnenl
TfA ¢<)mplinenlary therap￿5
P8tient support videos
Practitioner lor CART ￿11 therapy
Immoi*ilisation boards
16,OCN)
26.0(X)
12,000
8,500
4.586
40,0
2,250
187,0(X)
9,528
3.228
5,5C(I
672.674
31.789
53.874
318,000
25,000
Decorating cancer support qU￿t r(%)m and d&￿￿1 trials room
Pilot ECG lip syst&m
Surface guid8(I r8diothèrapy system
CardLqc monitor5
Auto O￿tlIn1￿9 software
8rachythèrapy HDR
Bariati¢ tr011gy
Page 14

rHE FRIENDS OF BRISTOL HAEMATOLQGY AND ONCOLOGY CENTRE
YOTES TO TrIE FINANCIAL STATEMENTS FOR THE YEAR ENDED
31 DECEMBER 2023
IS. Ro¢on¢lllation of net movemgnt in funds to ¢a$h flow from opgratlng •etl¥ltl•s
2023
2022
Net movemenl in funds
Less inv8stment income
Less10sslg8ins on investments
Decreasellincr8asel in debtors
{Decrease￿Ine￿as8 in creditors
252,175
1108,8221
1217,0211
28,451
11,6521
1243.5591
198.089)
373,568
128,9851
11.9381
Net cash generaied by oper8tlng act￿￿88
146,8691
997
Page 15